Priority Date: 16.02.12 (CN 2012134872)

MACROCYCLIC COMPOUNDS FOR SUPPRESSING REPLICATION OF HEPATITIS C VIRUS

  • Application ID: EP12868766
  • Status: EXAMINATION IN PROGRESS

Attorneys

Employment test 11 - 50 employees
Company dna gulde hengelhaupt ziebig and schneider
operating since 1990
Headquarter in Berlin and 6 offices
active in Legal Services and IP Consulting
Employment test 51 - 200 employees
Company dna prinz and partner
operating since 1928
Headquarter in Munich and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 222 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 16.02.2012 - Priority Date (CN 2012134872)
  • 22.08.2013 - Publication A1 (WO2013120371)
  • 24.12.2014 - Publication A1 (EP2816054)

IPC Classification